Article

Acupuncture for Knee Osteoarthritis not so Effective After All

According to researchers from MD Anderson Cancer Center, patients with osteoarthritis of the knee do not experience any more benefit with tradition Chinese acupuncture (TCA) than those receiving sham acupuncture (placebo).

According to researchers from MD Anderson Cancer Center, patients with osteoarthritis of the knee do not experience any more benefit with tradition Chinese acupuncture (TCA) than those receiving sham acupuncture (placebo).

However, the communication style of the acupuncturist may have a significant effect on pain reduction and satisfaction in patients. The research will be published in Arthritis Care & Research.

The findings come from a study performed by Maria Suarez-Almazor, MD, PhD, and colleagues, that compared the efficacy of TCA with sham acupuncture on OA of the knee. The researchers also measured provider-patient interactions in response to acupuncture. The study included 455 knee OA patients and 72 healthy controls. The acupuncture groups, both sham and TCA, were told by their acupuncturist that they had had great success in the past with treating knee pain or that it may, or may not work for the patient.

No statistically significant differences were reported between patients in the TCA and sham groups, but a small significant affect on pain and satisfaction with treatment was reported. The researchers saw this difference as a result of the different communication styles.

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
© 2024 MJH Life Sciences

All rights reserved.